Suppositories

Guide to cannabis suppositories — how rectal and vaginal administration delivers cannabinoids, bioavailability advantages, medical use cases including nausea and pelvic pain, and dosing guidance.

Category

Other

Onset

15-30 minutes

Duration

4-8 hours

Bioavailability

High (50-70% estimated)

Discretion

high

Health Risk

low

Health & Safety Notice

This information is for educational purposes only. Cannabis affects individuals differently based on biology, tolerance, and method. Always start with a low dose and consult a healthcare provider before using cannabis, especially if you take other medications.

Overview

Cannabis suppositories are small, bullet-shaped doses of cannabis extract in a base of cocoa butter, coconut oil, or a similar carrier that melts at body temperature. They are inserted rectally or vaginally, where the cannabinoids are absorbed through the mucosal lining. While less discussed than other consumption methods, suppositories offer unique pharmacological advantages that make them invaluable for certain patient populations. Rectal administration partially bypasses first-pass liver metabolism (approximately 50-70% of the dose avoids hepatic processing), potentially providing higher bioavailability than oral consumption with reduced psychoactive intensity.

Suppositories are particularly important for patients who cannot use other methods — those with severe nausea or vomiting (common during chemotherapy), difficulty swallowing (post-surgical, throat conditions), respiratory conditions that preclude inhalation, or gastrointestinal conditions that impair oral absorption. Vaginal suppositories have gained significant attention for menstrual pain, endometriosis, pelvic floor dysfunction, and sexual wellness applications. Despite the social stigma around this administration route, suppositories are a well-established pharmaceutical delivery method used for many medications, and they deserve recognition as a legitimate and often superior cannabis delivery option for appropriate conditions.

How It Works

When a suppository is inserted rectally, the carrier base (cocoa butter or coconut oil) melts at body temperature, releasing the cannabinoids against the rectal mucosa. The rectum is lined with a network of hemorrhoidal veins that drain into two pathways: the lower and middle rectal veins drain directly into the systemic circulation via the inferior vena cava, bypassing the liver entirely, while the superior rectal vein drains into the portal system and passes through the liver. This dual-pathway anatomy means that approximately 50-70% of rectally administered cannabinoids can bypass first-pass metabolism, resulting in higher systemic bioavailability than oral consumption. Because less THC is converted to the more potent 11-OH-THC, many patients report less psychoactive intensity compared to edibles at equivalent doses, while still receiving significant systemic and local therapeutic effects. Vaginal suppositories work through absorption by the vaginal mucosa and provide both local effects (for pelvic/uterine conditions) and some systemic absorption, with cannabinoids interacting with the dense concentration of cannabinoid receptors found in reproductive tissues.

Who Is This For?

Best For

  • +Patients unable to inhale or swallow medication
  • +Severe nausea or vomiting patients (chemotherapy, morning sickness)
  • +Pelvic pain, menstrual cramps, and localized lower-body conditions
  • +Patients seeking high bioavailability with reduced psychoactive effects

Not Recommended For

  • -Users uncomfortable with rectal or vaginal administration
  • -Casual or recreational consumers
  • -Those who prefer conventional consumption methods

Pros & Cons

Pros

  • High bioavailability (estimated 50-70%) exceeding oral consumption
  • Viable option for patients who cannot inhale, eat, or swallow medication
  • Reduced psychoactive intensity compared to edibles at similar doses due to partial bypass of first-pass metabolism
  • Excellent for localized pelvic, rectal, and lower abdominal conditions
  • Relatively fast onset (15-30 minutes) with long duration (4-8 hours)

Cons

  • Social stigma and discomfort with the administration method
  • Limited product availability in many cannabis markets
  • Research on rectal/vaginal cannabis pharmacokinetics is still limited
  • Cannot be easily dose-adjusted once administered
  • May cause local irritation or sensitivity in some individuals

Dosing Guide

Cannabis suppositories are typically available in doses ranging from 10-100mg THC or CBD per unit. Because of the higher bioavailability compared to oral consumption, beginners should start at the lower end of the dosing range — a 10-25mg suppository is a reasonable starting point for patients without existing tolerance. For patients with established tolerance or high symptom burden, 25-100mg doses are common. Insert the suppository and remain lying down for at least 15-20 minutes to prevent expulsion and allow the carrier to melt completely. Effects typically begin within 15-30 minutes. For menstrual pain or pelvic conditions, vaginal suppositories containing 25-100mg CBD with or without THC are commonly used, inserted 15-30 minutes before the onset of expected symptoms.

For more detailed dosing information, visit our comprehensive dosing guide.

Safety Tips

  • 1Store suppositories in the refrigerator to maintain their shape — they will melt at body temperature and can soften in warm environments
  • 2Wash hands thoroughly before and after insertion, and consider using a disposable glove
  • 3Remain lying down for 15-20 minutes after insertion to ensure the suppository stays in place and melts properly
  • 4Start with a low dose and increase gradually, as rectal bioavailability is higher than oral
  • 5Consult with a healthcare provider before using cannabis suppositories, especially if you have rectal or vaginal conditions

Frequently Asked Questions

Do cannabis suppositories get you high?

The psychoactive effects from cannabis suppositories are generally reported as milder than those from edibles at equivalent THC doses. This is because rectal administration partially bypasses first-pass liver metabolism, meaning less THC is converted to the highly potent 11-OH-THC metabolite. However, suppositories do deliver THC systemically, so psychoactive effects are possible, especially at higher doses. Many medical patients specifically choose suppositories for this reduced psychoactive profile while maintaining therapeutic benefits.

Who should consider using cannabis suppositories?

Suppositories are particularly valuable for patients with severe nausea or vomiting (chemotherapy patients, hyperemesis), those who cannot swallow (post-surgical, throat conditions, neurological disorders), patients with GI conditions that impair oral absorption (Crohn's, gastroparesis), individuals with pelvic pain (menstrual cramps, endometriosis, pelvic floor dysfunction), and patients who need high bioavailability without the intense psychoactive effects of edibles. They are a medical tool, not typically a recreational choice.

How do rectal and vaginal suppositories differ?

Rectal suppositories primarily deliver systemic effects through absorption by the rectal venous system, with some local benefits for rectal and lower GI conditions. Vaginal suppositories are designed primarily for local effects — cannabinoids interact with the abundant endocannabinoid receptors in reproductive tissues, providing targeted relief for menstrual cramps, endometriosis, vulvodynia, and pelvic floor tension. Vaginal administration does provide some systemic absorption but is generally less systemically bioavailable than rectal administration.

Are cannabis suppositories well-researched?

Cannabis suppositories are less thoroughly studied than oral or inhaled cannabis. The pharmacokinetics of rectal THC administration have been explored in a limited number of studies, with results suggesting higher bioavailability than oral but less than inhalation. Anecdotal evidence from patients is strongly positive, particularly for nausea, pelvic pain, and conditions where other routes are not viable. More clinical research is needed to fully characterize the pharmacokinetics, optimal dosing, and therapeutic applications of this delivery method.

Related Methods

Explore More